Nuclear factor-κB1:: Regulation and function

被引:176
|
作者
Pereira, Silvia Gaspar [1 ]
Oakley, Fiona [1 ]
机构
[1] Univ Newcastle, Inst Cellular Med, Liver Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
来源
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY | 2008年 / 40卷 / 08期
基金
英国医学研究理事会; 英国惠康基金;
关键词
p50; p105; signaling; function;
D O I
10.1016/j.biocel.2007.05.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The transcription factor NF-kappa B is a critical regulator of many cellular processes including cell survival and inflammation. NF-kappa B functions as a hetero- or homo-dimer which can be formed from five NF-kappa B subunits, NF-kappa B1 (p50 and its precursor p105), NF-kappa B2 (p52 and its precursor p100), RelA (p65), RelB and c-Rel. The most studied dimer is p50:p65, which is activated by the classical pathway and usually promotes gene expression. Activation of p50:p65 is linked with cell survival and promoting inflammation. This review provides a detailed overview of the structure, synthesis and function of the lesser characterised NF-kappa B subunit; NF-kappa B1 (p 105 and p50). The diverse interactions of NF-kappa B1 with co-activators, co-repressors and other signaling networks that influence NF-kappa B1 gene expression are discussed. Finally the anti-inflammatory actions of NF-kappa B1 signaling will be assessed and the crucial need to design novel therapeutic drugs which exploit and amplify the anti-inflammatory actions of p50 will be explored. (C) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1425 / 1430
页数:6
相关论文
共 50 条
  • [11] Liver Kinase B1 Is Required for Thromboxane Receptor-Dependent Nuclear Factor-κB Activation and Inflammatory Responses
    He, Jinlong
    Zhou, Yanhong
    Xing, Junjie
    Wang, Qilong
    Zhu, Huaiping
    Zhu, Yi
    Zou, Ming-Hui
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2013, 33 (06) : 1297 - +
  • [12] cDNA microarray analysis reveals a nuclear factor-κB-independent regulation of macrophage function by adenosine
    Németh, ZH
    Leibovich, SJ
    Deitch, EA
    Vizi, ES
    Szabó, C
    Haskó, G
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 306 (03): : 1042 - 1049
  • [13] Receptor activator of nuclear factor-κB ligand activates nuclear factor-κB in osteoclast precursors
    Wei, S
    Teitelbaum, SL
    Wang, MWH
    Ross, FP
    ENDOCRINOLOGY, 2001, 142 (03) : 1290 - 1295
  • [14] Transcriptional regulation of Notch1 by nuclear factor-κB during T cell activation
    Hwang, Jeong-Ryul
    Kim, Donghwan
    Kang, Jung-Ah
    Park, Sang-Heon
    Park, Sung-Gyoo
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [15] New insights into the role of nuclear factor-κB in cell growth regulation
    Chen, F
    Castranova, V
    Shi, XL
    AMERICAN JOURNAL OF PATHOLOGY, 2001, 159 (02): : 387 - 397
  • [16] Transcriptional regulation of Notch1 by nuclear factor-κB during T cell activation
    Jeong-Ryul Hwang
    Donghwan Kim
    Jung-Ah Kang
    Sang-Heon Park
    Sung-Gyoo Park
    Scientific Reports, 13
  • [17] Nuclear Factor-κB-Mediated Regulation of Telomerase The Myc Link
    Wang, Julie C.
    Bennett, Martin R.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2010, 30 (12) : 2327 - 2328
  • [18] Nuclear factor-?B signalling and transcriptional regulation in skeletal muscle atrophy
    Jackman, Robert W.
    Cornwell, Evangeline W.
    Wu, Chia-Ling
    Kandarian, Susan C.
    EXPERIMENTAL PHYSIOLOGY, 2013, 98 (01) : 19 - 24
  • [19] Endothelial Nuclear Factor-κB-Dependent Regulation of Arteriogenesis and Branching
    Tirziu, Daniela
    Jaba, Irina M.
    Yu, Pengchun
    Larrivee, Bruno
    Coon, Brian G.
    Cristofaro, Brunella
    Zhuang, Zhen W.
    Lanahan, Anthony A.
    Schwartz, Martin A.
    Eichmann, Anne
    Simons, Michael
    CIRCULATION, 2012, 126 (22) : 2589 - 2600
  • [20] Nuclear factor-κB inhibition in sepsis:: Steroids versus specific nuclear factor-κb inhibitors?
    Marik, PE
    CRITICAL CARE MEDICINE, 2002, 30 (10) : 2393 - 2394